(Q40211193)

18 September 2017

title

Biological diagnosis of meningococcal meningitis in the African meningitis belt: current epidemic strategy and new perspectives (English)

1 reference

18 September 2017

1 reference

meningococcal meningitis

1 reference

1

Suzanne Chanteau

1 reference

18 September 2017

Angela M C Rose

2

1 reference

18 September 2017

Saacou Djibo

series ordinal

3

1 reference

18 September 2017

Farida Nato

series ordinal

4

1 reference

18 September 2017

Pascal Boisier

series ordinal

5

1 reference

18 September 2017

language of work or name

English

0 references

publication date

7 May 2007

1 reference

18 September 2017

1 reference

18 September 2017

volume

25 Suppl 1

1 reference

18 September 2017

page(s)

A30-6

1 reference

Manson Lecture. Meningococcal meningitis in Africa

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.037

Clonal expansion of sequence type (ST-)5 and emergence of ST-7 in serogroup A meningococci, Africa.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.037

Outbreaks of serogroup X meningococcal meningitis in Niger 1995-2000

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.037

Prospective study of a serogroup X Neisseria meningitidis outbreak in northern Ghana

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.037

Meningococcal Meningitis: Unprecedented Incidence of Serogroup X--Related Cases in 2006 in Niger

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.037

Evaluation of the Pastorex meningitis kit for the rapid identification of Neisseria meningitidis serogroups A and W135.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.037

High sensitivity and specificity of the Pastorex® latex agglutination test for Neisseria meningitidis serogroup A during a clinical trial in Niger

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.037

Latex particle agglutination test in the diagnosis of Haemophilus influenzae type B, Streptococcus pneumoniae and Neisseria meningitidis A and C meningitis in infants and children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.037

Bacterial antigen detection in cerebrospinal fluid of patients with meningitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.037

Ultrasound enhanced detection of individual meningococcal serogroups by latex immunoassay.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.037

Ceftriaxone as effective as long-acting chloramphenicol in short-course treatment of meningococcal meningitis during epidemics: a randomised non-inferiority study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.037

Nucleotide sequence and expression of the pneumococcal autolysin gene from its own promoter in Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.037

Epidemiological patterns of meningococcal meningitis in Niger in 2003 and 2004: under the threat of N. meningitidis serogroup W135.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.037

Bacterial meningitis in Burkina Faso: surveillance using field-based polymerase chain reaction testing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.037

Scaling up of PCR-based surveillance of bacterial meningitis in the African meningitis belt: indisputable benefits of multiplex PCR assay in Niger.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.037

New rapid diagnostic tests for Neisseria meningitidis serogroups A, W135, C, and Y.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.037

Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.037

Predicting the Stability of Biological Standards and Products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.037

Development of rapid one-step immunochromatographic assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.037

Quality assurance study of bacterial antigen testing of cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.04.037

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2007.04.037

1 reference

18 September 2017

1 reference